The drug’s failure is a major disappointment for ALS patients and advocates who pressed the FDA to approve it back in 2022.said Thursday it will pull the medicine from the market, acknowledging it didn't help patients with the deadly neurological condition.
“While this is a difficult moment for the ALS community, we reached this path forward in partnership with the stakeholders who will be impacted and in line with our steadfast commitment to people living with ALS," company co-founders said in a statement. Patients already taking the therapy who wish to continue will be able to enroll in a program to receive it for free.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: IntEngineering - 🏆 287. / 63 Read more »
South Korean police catch $4.1M crypto scam duoThe scammers falsely guaranteed 70% profits on an investment of 1 billion won within a month and stole 5.5 billion won over six different transactions.
Source: Cointelegraph - 🏆 562. / 51 Read more »